Abstract
23P Clinical impact and prognostic value of EGFR mutation co-occurring with ALK, ROS1, RET fusions, or MET exon 14 skipping mutations in Chinese patients with non-small cell lung cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have